U.S. federal trademark · Serial No. 75826322
Pharmaceuticals for use in treatment of cancer, namely platinum and liposomal drugs for use in the treatment of colon, lung, prostate, breast, ovarian, renal and bladder cancer, Pseudomyxome peritonei, multiple yeoman, chronic lymphocytic leukemia, testicular malignancies, malignant effusions, and malignant mesothelioma
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.